These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Liposomal vaccine delivery systems. Henriksen-Lacey M; Korsholm KS; Andersen P; Perrie Y; Christensen D Expert Opin Drug Deliv; 2011 Apr; 8(4):505-19. PubMed ID: 21413904 [TBL] [Abstract][Full Text] [Related]
4. Nanoparticles and microparticles as vaccine-delivery systems. Singh M; Chakrapani A; O'Hagan D Expert Rev Vaccines; 2007 Oct; 6(5):797-808. PubMed ID: 17931159 [TBL] [Abstract][Full Text] [Related]
5. Immunoliposomes for cancer therapy. Kontermann RE Curr Opin Mol Ther; 2006 Feb; 8(1):39-45. PubMed ID: 16506524 [TBL] [Abstract][Full Text] [Related]
6. [Recent advances in liposomes and nanoparticles as drug carriers for drug delivery]. Liu Y; Lü WL; Zhang Q Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):583-9. PubMed ID: 16995319 [TBL] [Abstract][Full Text] [Related]
7. Liposome-based delivery system for vaccine candidates: constructing an effective formulation. Giddam AK; Zaman M; Skwarczynski M; Toth I Nanomedicine (Lond); 2012 Dec; 7(12):1877-93. PubMed ID: 23249332 [TBL] [Abstract][Full Text] [Related]
9. [Adjuvants--essential components of new generation vaccines]. Dzierzbicka K; Kołodziejczyk AM Postepy Biochem; 2006; 52(2):204-11. PubMed ID: 17078510 [TBL] [Abstract][Full Text] [Related]
10. Liposomal cytokines and liposomes targeted to costimulatory molecules as adjuvants for human immunodeficiency virus subunit vaccines. Ozpolat B; Lachman LB Methods Enzymol; 2003; 373():92-100. PubMed ID: 14714398 [No Abstract] [Full Text] [Related]
11. Liposomes composed of reconstituted membranes for induction of tumor-specific immunity. Westerman LE; Jensen PE Methods Enzymol; 2003; 373():118-27. PubMed ID: 14714400 [No Abstract] [Full Text] [Related]
12. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators. Nordly P; Madsen HB; Nielsen HM; Foged C Expert Opin Drug Deliv; 2009 Jul; 6(7):657-72. PubMed ID: 19538037 [TBL] [Abstract][Full Text] [Related]
16. Liposomes as carrier and immunoadjuvant of vaccine antigens. van Rooijen N Adv Biotechnol Processes; 1990; 13():255-79. PubMed ID: 2185785 [No Abstract] [Full Text] [Related]
17. Mucosal delivery of vaccines in domestic animals. Gerdts V; Mutwiri GK; Tikoo SK; Babiuk LA Vet Res; 2006; 37(3):487-510. PubMed ID: 16611560 [TBL] [Abstract][Full Text] [Related]
18. Liposomes targeted to Fc receptors for antigen presentation by dendritic cells in vitro and in vivo. Serre K; Giraudo L; Leserman L; Machy P Methods Enzymol; 2003; 373():100-18. PubMed ID: 14714399 [No Abstract] [Full Text] [Related]
19. Preparation of prospective plant oil derived micro-emulsion vehicles for drug delivery. Gupta S; Sanyal SK; Datta S; Moulik SP Indian J Biochem Biophys; 2006 Aug; 43(4):254-7. PubMed ID: 17133772 [TBL] [Abstract][Full Text] [Related]
20. A novel procedure for preparation of submicron liposomes-lyophilization of oil-in-water emulsions. Wang T; Wang N; Jin X; Zhang K; Li T J Liposome Res; 2009; 19(3):231-40. PubMed ID: 19263267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]